Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbinger Health
Cambridge, Massachusetts, United Statesharbinger-health.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Harbinger Health has developed a proprietary platform that uses artificial intelligence and unique insights into the biology of cancer’s origin to detect multiple cancers at their earliest stages via blood-based tests. The company’s Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) study enrolled over 8,000 participants to validate its approach, showing promise in sensitivity and specificity for detecting both solid and hematologic malignancies before symptoms arise. Two late-breaking presentations at AACR 2025 highlighted analytical innovations improving performance assessment and clinical utility of their MCED tests. Commercial launch is anticipated in 2025.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic testBlood-based assayDNA methylation profiling
- Industry
- Molecular Diagnostics
02
Partnerships
Sarah Cannon Research Institute – partnered for the CORE-HH study clinical validationLeading U.S. cancer center partnership announced November 2024 to accelerate evidence generation
Beyond the preview
Go deeper on Harbinger Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Harbinger Health.